Skip to main content
Dr. Reddy's Laboratories Limited (BOM:500124)
India flag India · Delayed Price · Currency is INR
1,286.40
-17.50 (-1.34%)
At close: Mar 9, 2026

Dr. Reddy's Laboratories Revenue

Dr. Reddy's Laboratories had revenue of 87.27B INR in the quarter ending December 31, 2025, with 4.41% growth. This brings the company's revenue in the last twelve months to 345.83B, up 11.09% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.

Revenue (ttm)
345.83B
Revenue Growth
+11.09%
P/S Ratio
3.10
Revenue / Employee
12.44M
Employees
27,811
Market Cap
1,071.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025325.54B46.37B16.61%
Mar 31, 2024279.16B33.29B13.54%
Mar 31, 2023245.88B31.49B14.69%
Mar 31, 2022214.39B24.67B13.00%
Mar 31, 2021189.72B15.12B8.66%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Lupin 261.51B
Torrent Pharmaceuticals 127.42B
Abbott India 68.24B
GlaxoSmithKline Pharmaceuticals 38.01B
J. B. Chemicals & Pharmaceuticals 41.93B
AstraZeneca Pharma India 21.77B
Granules India 50.92B
Jubilant Pharmova 79.18B
Revenue Rankings

Dr. Reddy's Laboratories News

More News